Your Trusted Contract Development and Manufacturing Organization Accelerate your drug development program with reliable, expert pharmaceutical research from our team. We go beyond laboratory testing services to support every aspect of your project, including preclinical support, formulation, process development, clinical supplies manufacturing, and more. Powered by decades of experience, our team offers strategic insights and […]
Pace® Services for Pharmaceuticals and Biotech Pace® supports numerous aspects of the pharmaceutical and biotech lifecycle, from research and development to commercialization and facility management. No matter the scale of your operations, our technical expertise and exemplary customer service fill the gaps and empower progress with integrated offerings. Contact Us Areas of Expertise Small Molecule
Pharma/Biopharmaceutical Read More »
Pace® Services for Medical Devices From finished products to facilities, we support the medical device industry with comprehensive on and off-site services. Like all manufacturers, medical device manufacturers need to ensure their air, water, and waste is free from contaminants, cleanrooms are certified and monitored, and lab equipment is maintained to operate at peak performance.
Pace® Services for Healthcare Organizations Pace® testing and advisory services help healthcare organizations meet strict regulatory standards and ensure the health and safety of their patients and employees. Our expert team can identify potential risks and vulnerabilities from waterborne pathogens and other contaminants and share insights on mitigation best practices. Using the latest advancements in
Greg Kupp – President Life Sciences Division & Frank Tagliaferri – VP of Technical DevelopmentPace® Life Sciences were recently interviewed by Investment Reports. Read the full inter view here.
Pace ® is happy to share news from our client, ReveraGen BioPharma Inc., on a significant accomplishment! ReveraGen Completes NDA Submission to FDA for Vamorolone in Duchenne Muscular Dystrophy. Pace® Ann Arbor (legacy Velesco Pharmaceutical Services) contributed significantly to this success. Velesco Pharma (now Pace®) performed the drug product clinical formulation development and all drug
ReveraGen Completes NDA Submission to FDA for Vamorolone in Duchenne Muscular Dystrophy Read More »
Acquisition allows Pace® to provide full-service regulatory strategy and consulting services to advance FDA submissions across a wide range of therapeutic classes. Minneapolis, MN, September 1, 2022 – Pace® Life Sciences, LLC, a full-service contract development and manufacturing organization (CDMO) and subsidiary of Pace®, ascience and technology company, announced today that it has acquired Biopharma
First Wave BioPharma Chooses Pace® Life Sciences as CDMO Partner. BOCA RATON, Fla., Sept. 07, 2022 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced today the selection of an enhanced enteric microgranule
Research involves microgranule delivery formulations for adrulipase BOCA RATON, Fla., Aug. 31, 2022 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced today that an abstract titled, “Formulation Development of Enterically Protected Spray Dried
Acquisition allows Pace® to provide regulatory and quality consulting services to support clients throughout the drug development process and improve commercial compliance in FDA-regulated environments. Minneapolis, MN, August 18, 2022 – Pace® Life Sciences, LLC, a full-service contract development and manufacturing organization (CDMO) and subsidiary of Pace® Science and Technology Company, announced today that it